|
Four potential blockbusters in the Pharma pipeline
|
20 December 2011 |
|
Bayer plans further expansion in Asia
|
16 November 2011 |
|
After a good third quarter: Bayer confirms Group outlook
|
28 October 2011 |
|
Bayer HealthCare and Onyx Pharmaceuticals Restructure Global Oncology Partnership
|
17 October 2011 |
|
Bayer Confident in Results of ROCKET AF Study
|
07 September 2011 |
|
Bayer Healthcare to acquire Pathway Medical Technologies
|
01 September 2011 |
|
FDA Grants Fast Track Designation to Bayer's Investigational Compound Alpharadin™
|
23 August 2011 |
|
Bayer to support WHO and Stop Tuberculosis Partnership in fighting tuberculosis
|
15 August 2011 |
|
Results of ROCKET AF Study of Bayer’s Xarelto® (Rivaroxaban)
|
11 August 2011 |
|
Bayer continues positive momentum
|
01 August 2011 |
|
Bayer advances research in the area of pulmonary hypertension
|
01 July 2011 |
|
Major Subgroup Analysis Shows Bayer's Rivaroxaban is Highly Effective in the Prevention of Recurrent Strokes
|
26 May 2011 |
|
Bayer off to a successful start to 2011
|
02 May 2011 |
|
Bayer affirms the positive benefit-risk profile of its drospirenone- containing oral contraceptives
|
26 April 2011 |
|
Bayer's Rivaroxaban Submitted for Approval in Japan
|
15 April 2011 |
|
Bayer and Regeneron Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema
|
11 April 2011 |
|
OncoTrack: A new International consortium launches project in the area of genomic cancer diagnostics
|
13 March 2011 |
|
Bayer extends support to fight Chagas disease
|
04 March 2011 |
|
Breaking the Taboo Associated with Hemorrhoidal Disease
|
02 March 2011 |
|
Bayer and Onyx Initiate Phase III Trial of Nexavar® in Combination with Chemotherapy
|
24 February 2011 |